Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-246,429
Closed -$19.8M 397
2022
Q4
$19.8M Sell
246,429
-62,000
-20% -$4.74M 0.35% 54
2022
Q3
$20.6M Buy
+308,429
New +$22.8M 0.36% 56
2022
Q1
$44.5M Hold
606,000
0.22% 103
2021
Q4
$44.5M Hold
606,000
0.22% 103
2021
Q3
$41.7M Buy
606,000
+170,000
+39% +$12.9M 0.22% 118
2021
Q2
$36.7M Buy
436,000
+173,000
+66% +$14.4M 0.16% 151
2021
Q1
$21.4M Buy
263,000
+113,000
+75% +$9.64M 0.09% 210
2020
Q4
$13M Hold
150,000
0.06% 252
2020
Q3
$13.5M Hold
150,000
0.07% 214
2020
Q2
$15.6M Sell
150,000
-16,000
-10% -$1.54M 0.09% 206
2020
Q1
$12.2M Buy
+166,000
New +$12.5M 0.09% 201

Other funds holding INCY

PGGM Investments's INCY Position: Q1 2023 in Review

PGGM Investments sold out of Incyte (INCY) in Q1 2023, closing a stake of 246,429 shares — an estimated $19.8M sold.

PGGM Investments first reported a position in INCY in Q1 2020 and held it in 11 quarters. The position peaked at $44.5M in Q1 2022. 550 funds tracked by Wall St. Rank hold INCY as of Q1 2023.

  • PGGM Investments reported no remaining Incyte position as of Q1 2023 after selling out during the quarter.
  • PGGM Investments sold 246,429 Incyte shares in Q1 2023, an estimated $19.8M.
  • PGGM Investments first reported a position in Incyte in Q1 2020 and held it in 11 quarters.
  • PGGM Investments's Incyte position peaked at $44.5M in Q1 2022.
  • 550 funds tracked by Wall St. Rank held Incyte as of Q1 2023.

Based on PGGM Investments's 13F filing for Q1 2023, filed 11 May 2023.